|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Amortization of intangible assets | |||||
| Recovery of provision for credit losses | |||||
| Depreciation of premises and equipment | |||||
| Amortization (accretion) of deferred loan (fees) costs, net | |||||
| Amortization of premiums and accretion of discounts on securities, net | |||||
| Deferred income tax benefit expense | |||||
| Gain on sale of loans | |||||
| Proceeds from sale of loans | |||||
| Origination of loans held for sale | |||||
| Loss on sale of securities | |||||
| Gain on sale of premises and equipment | |||||
| Increase in cash surrender value of bank owned life insurance | |||||
| Employee stock ownership plan | |||||
| Stock based compensation | |||||
| Changes in | |||||
| Accrued interest receivable | |||||
| Net changes in other assets | |||||
| Net changes in other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of securities available for sale | |||||
| Purchases of securities held to maturity | |||||
| Maturities, calls, and repayments of securities available for sale | |||||
| Maturities, calls, and repayments of securities held to maturity | |||||
| Proceeds from sale of securities | |||||
| Proceeds from sale of premises and equipment | |||||
| Net decrease (increase) in loans | |||||
| Purchase of bank owned life insurance | |||||
| Proceeds from sale of loans from portfolio | |||||
| Purchase of equity investment | |||||
| Purchases of premises and equipment | |||||
| Purchase of FHLB stock | |||||
| Redemption of FHLB stock | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Net increase (decrease) in deposits | |||||
| Net decrease in short-term FHLB advances | |||||
| Proceeds of long-term FHLB non-repo advances | |||||
| Net increase (decrease) in advance payments from borrowers for taxes and insurance | |||||
| Repurchase of common stock | |||||
| Net cash provided (used in) by financing activities | |||||
| Cash and cash equivalents – beginning of year | |||||
| Cash and cash equivalents – end of year | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents – beginning of year | |||||
| Cash and cash equivalents – end of year | |||||
| Supplemental cash flow information | |||||
| Income taxes paid | |||||
| Interest paid | |||||
| Fair value change in derivatives | |||||
| Fair value change in fair value hedges | |||||
| Non-cash investment and financing activities | |||||
| Right of use asset | |||||
| Lease liability | |||||
| Transfer of held to maturity securities to available for sale | |||||
Loading...